Protein-Protein Interactions / edited by Michael D. Wendt
(Topics in Medicinal Chemistry. ISSN:18622461 ; 8)
データ種別 | 電子ブック |
---|---|
著者標目 | Wendt, Michael D editor SpringerLink (Online service) |
出版情報 | 製作表示:Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer , 2012 |
書誌詳細を非表示
巻次 | ISBN:9783642289651 |
---|---|
大きさ | XVIII, 262 p : online resource |
一般注記 | Protein-Protein Interactions as Drug Targets -- Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics -- The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer -- Protein-Protein Interaction Targets to Inhibit HIV-1 Infection -- Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus -- Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces -- The Discovery of Navitoclax, a Bcl-2 Family Inhibitor Michael D. Wendt Protein-Protein Interactions as Drug Targets Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics Kurt Deshayes , Jeremy Murray , Domagoj Vucic The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto Protein-Protein Interaction Targets to Inhibit HIV-1 Infection Nicholas A. Meanwell , David R. Langley Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces Michael D. Wendt The Discovery of Navitoclax, a Bcl-2 Family Inhibitor HTTP:URL=https://doi.org/10.1007/978-3-642-28965-1 |
件 名 | LCSH:Chemistry FREE:Chemistry/Food Science, general |
分 類 | LCC:QD1-999 DC23:540 |
書誌ID | OB00007210 |
ISBN | 9783642289651 |